Advertisement

Cambridge, Mass.-based Genzyme Corp., a subsidiary of French drug maker Sanofi (NYSE: SNY), has been ordered to pay $50 million to privately-held New Jersey-based biotechnology company Shelbyzyme LLC.

Advertisement
Advertisement